Boston Scientific Corp. recently received CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview mapping software to be used with its Farapulse pulsed field ablation (PFA) ...

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation Today, physicians may utilize a separate mapping ...

MARIETTA -- Memorial Health System's Department of Cardiology has announced the successful launch of the FARAPULSE Pulsed Field Ablation procedure. On May 8, Cardiac Electrophysiologist Dr. Maninder ...

In December 2023, Boston Scientific Corporation (NYSE: BSX) initiated the AVANT GUARD trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System as a first-line ...

A Boston Scientific (NYSE:BSX) executive said today that the company enrolled the first patients in a new pulsed field ...

Editor's note: This is the first of a two-part series on the Boston Scientific Investor Day presentation. This first part focuses on the company's Farapulse pulsed field ablation system. Part two will ...

Boston Scientific just became the second company to cross the FDA finish line in the pulsed field ablation (PFA) market. The company's Farapulse PFA system, which was first-to-market in Europe, is one ...

- Large, Randomized Controlled ADVENT Trial Designed to Establish New Gold Standard for AF Ablation - MENLO PARK, Calif., Dec. 17, 2020/PRNewswire/ - FARAPULSE Inc. ("FARAPULSE" or "the Company") ...

- FARAPULSE becomes first company in the world to commercialize a cardiac PFA system - MENLO PARK, Calif., Jan. 29, 2021 /PRNewswire/ - FARAPULSE Inc. ("FARAPULSE" or "the Company") today announced ...

(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...